Meeting of the Horizontal Working Party on Drugs, Brussel - Hoofdinhoud

• 1. 

  Adoption of the agenda

• 2. 

  Information on drug-related discussions at other Council bodies and on other drug-related developments

5730/20 5756/20

• 3. 

  EU-Iran Dialogue on Drugs - State of play

WK 10775/19 REV 3 6010/20

CM 1261/1/20 REV 1

1

EN

• 4. 

  EU-CELAC Coordination and Cooperation Mechanism on Drugs

• A. 

  Preparation of the Technical Committee Meeting (Brussels, 19 February 2020) CM 1497/1/20 REV 1

• B. 

  Preparation of the High Level Meeting (Zagreb, 2-3 April 2020)

• a) 

  Draft agenda

WK 10777/19 REV 3

• b) 

  Draft Outcome Document WK 13538/19 REV 4

• c) 

  Draft Annual Report WK 1705/20

• d) 

  Information by the Presidency on the event

• 5. 

  Preparation of the EU-Brazil Expert Meeting on Drugs (Vienna, 6 March 2020, 14.00-16.00) 5768/20

• 6. 

  Preparation of the EU-Western Balkans Expert Meeting on Drugs (Brussels, 23 April 2020)

• - 

  Presentation by the EMCDDA and Europol

• - 

  Discussion

WK 285/20

• 7. 

  Preparation for the EU National Drug Coordinators meeting (Zagreb, 14 May 2020) WK 1686/20

• 8. 

  Preparation of the EU-U.S. Dialogue on Drugs (Videoconference, Brussels, 27 May 2020) WK 1687/20

• 9. 

  Overview of the EU acquis applicable to cannabis in its different forms and components -state of play of the questions and comments received

WK 14407/2019

• 10. 

  Presentation by the Civil Society Forum on Drugs

• 11. 

  Preparation of the 63rd session of the CND (Vienna, 2-6 March 2020)

• A. 

  Report on recent developments in the CND, including informal and intersessional meetings and the proposals to create a follow-up mechanism to the WHO recommendations on cannabis and cannabis-related substances

CM 1261/1/20 REV 1

2

EN

• B. 

  International scheduling of cannabis and cannabis-related substances - State of play 5575/20

• - 

  Communication and explanation of positions

WK 1690/20 (to be issued) WK 1930/20 (to be issued)

• C. 

  Agreement on the EU statements for the session

WK 1480/20 REV 1, WK 1479/20 REV 1, WK 1442/20 REV 1, WK 1440/20 REV 1, WK 1701/20 REV 1, WK 1703/20 REV 1

• D. 

  Resolutions WK 1215/20

• E. 

  Side-events

WK 286/20 REV 1

• F. 

  Speakers and panellists

• G. 

  Annual Report Questionnaire

• 10. 

  AOB

• a) 

  France's candidacy to the CND (2022 - 2025)

• b) 

  Letter from the EMCDDA Scientific Committee to the Presidencies WK 1341/20

WK 12206/19

• c) 

  Information by the EMCDDA on the Futures workshop on drug policy in Europe (Brussels, 26 of May 2020)

NB: Council documents are available on Delegates Portal. Room attendants will provide copies on request at the earliest opportunity.

CM 1261/1/20 REV 1

3

EN